Drug News

Medindia's Press Release’ section provides the latest press release on Drug from across the world for the global audience. This page links to 12891 Drug press releases.

Sagent Pharmaceuticals Launches Pamidronate Disodium Injection

SCHAUMBURG, Ill., Jan. 19 Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 ...


Watson Confirms Filing of FDA Application for Generic Lidoderm(R)

MORRISTOWN, N.J., Jan. 19 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with ...

Consumers Union Disappointed with FDA's Action on BPA, Despite Admission of 'Some Concern'

YONKERS, N.Y., Jan. 15 Consumers Union, the nonprofit publisher of Consumer Reports, expressed disappointment with the U.S. Food & Drug Administration's (FDA) failure to ban the chemical bisphenol A (BPA), despite announcing today that ...

China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters

HARBIN, China, Jan. 15 China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ...

TLC to Premiere New Series - ADDICTED

LOS ANGELES, Jan. 14 Today, TLC announced plans to premiere ADDICTED, a one-hour docu-series following the lives of individuals struggling with addiction as they work with interventionist Kristina Wandzilak. Each riveting episode ...

PriCara(R) Launches PrescribeResponsibly.com to Support Responsible Prescribing of Opioid Medicines Used to Treat Pain

RARITAN, N.J., Jan. 14 PriCara,(® )Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today the launch of PrescribeResponsibly.com, a new Web site for healthcare professionals about the appropriate and responsible prescribing of ...

Bedford Laboratories(TM) To Begin Shipping Fluconazole Injection

BEDFORD, Ohio, Jan. 14 Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., is pleased to announce FDA approval for the addition of 100 mg/50 mL Fluconazole Injection to its existing Fluconazole Injection line. This product ...

Mail-Order Pharmacy Use Could Improve Patients' Medication Adherence

LOS ANGELES, Jan. 13 Buying mail-order medications may encourage patients to stick to their doctor-prescribed medication regimen, new research suggests. In a first-of-its-kind study, researchers from UCLA and Kaiser Permanente's ...

Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate

LAIYANG, China, Jan. 12 Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that one of its factories in China obtained a renewal of ...

Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)

SEATTLE, Jan. 11 Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) today announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is ...

Drug News »

Tirzepatide Treats Obesity Even in Diabetics and Those With Other Complications

Tirzepatide Treats Obesity Even in Diabetics and Those With Other Complications

The presence of medical conditions associated with obesity does not affect the overall weight loss attained with the use of the anti-obesity drug tirzepatide. This finding is as per a study supported by the industry, and will be ...

GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute Pancreatitis

GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute Pancreatitis

A recent study showed that the medicines Glucagon-like peptide-1receptor agonists (known as GLP-1 receptor agonists) prescribed for type 2 diabetes and obesity...

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

In a concerning revelation, the utilization of popular diabetes and weight loss drugs has been associated with an elevated risk of stomach paralysis, a rare yet severe condition known as gastroparesis . Emerging from comprehensive ...

 Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide's Multifaceted Benefits in Diabetes Treatment

Semaglutide , as highlighted by a groundbreaking study, offers substantial benefits by reducing the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients diagnosed with type 2 diabetes and chronic kidney disease ( )....

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

In response to the worldwide surge in H5N1 cases, American researchers have created an experimental mRNA vaccine , leveraging COVID-19 vaccine technology, to combat avian flu infections ( ). Preclinical models, detailed in the journal Nature ...

More Drug News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.